ADENIKE AKONEDO: Open Payments
NPI 1861022907 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 25 payments from 7 companies in 2025. Trend: 2023 $136 · 2024 $316 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $197 |
| Teva Pharmaceuticals USA, Inc. | 8 | $160 |
| ABBVIE INC. | 4 | $82 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Alkermes, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: INVEGA SUSTENNA, UZEDY, VRAYLAR, INGREZZA, ARISTADA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
